| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.911 | 0.005 | 0.911 | Transcription factor NF kappa B inhibitor | 0.411 0.061 DBMET00505 0.908 0.005 DBMET00715 | ||
| 0.889 | 0.005 | 0.889 | Antiinflammatory | 0.71 0.029 DBMET00505 0.88 0.006 DBMET00715 | ||
| 0.882 | 0.008 | 0.882 | Apoptosis agonist | 0.337 0.147 DBMET00505 0.842 0.012 DBMET00715 | ||
| 0.805 | 0.01 | 0.805 | Caspase 9 stimulant | 0.623 0.033 DBMET00505 0.781 0.014 DBMET00715 | ||
| 0.741 | 0.006 | 0.741 | Antibacterial | 0.407 0.074 DBMET00505 0.67 0.011 DBMET00715 | ||
| 0.739 | 0.005 | 0.739 | Nitric oxide antagonist | 0.157 0.089 DBMET00505 0.704 0.005 DBMET00715 | ||
| 0.698 | 0.005 | 0.698 | Immunosuppressant | 0.579 0.016 DBMET00505 0.655 0.007 DBMET00715 | ||
| 0.67 | 0.01 | 0.67 | Cholesterol antagonist | 0.625 0.015 DBMET00505 0.62 0.016 DBMET00715 | ||
| 0.659 | 0.011 | 0.659 | Antithrombotic | 0.461 0.035 DBMET00505 0.599 0.016 DBMET00715 | ||
| 0.652 | 0.004 | 0.652 | P-glycoprotein inhibitor | 0.623 0.005 DBMET00715 | ||
| 0.62 | 0.008 | 0.62 | Apoptosis antagonist | 0.573 0.013 DBMET00505 0.614 0.008 DBMET00715 | ||
| 0.53 | 0.005 | 0.53 | Interferon gamma antagonist | 0.297 0.02 DBMET00505 0.518 0.005 DBMET00715 | ||
| 0.481 | 0.008 | 0.481 | Hepatoprotectant | 0.274 0.037 DBMET00505 0.458 0.009 DBMET00715 | ||
| 0.485 | 0.022 | 0.504 | Antioxidant | 0.504 0.019 DBMET00505 0.492 0.021 DBMET00715 | DBMET00505 | |
| 0.477 | 0.014 | 0.585 | Hypolipemic | 0.585 0.007 DBMET00505 0.405 0.024 DBMET00715 | DBMET00505 | |
| 0.456 | 0.005 | 0.46 | Lipocortins synthesis antagonist | 0.359 0.012 DBMET00505 0.46 0.005 DBMET00715 | DBMET00715 | |
| 0.454 | 0.007 | 0.454 | Sodium/bile acid cotransporter inhibitor | 0.452 0.007 DBMET00505 0.449 0.008 DBMET00715 | ||
| 0.442 | 0.003 | 0.442 | Cholesterol synthesis inhibitor | 0.278 0.014 DBMET00505 0.41 0.004 DBMET00715 | ||
| 0.451 | 0.037 | 0.451 | Immunostimulant | 0.401 0.049 DBMET00505 0.409 0.047 DBMET00715 | ||
| 0.44 | 0.032 | 0.44 | Caspase 3 stimulant | 0.411 0.041 DBMET00715 | ||
| 0.407 | 0.011 | 0.407 | Platelet adhesion inhibitor | 0.311 0.03 DBMET00505 0.37 0.015 DBMET00715 | ||
| 0.392 | 0.029 | 0.479 | Hypoglycemic | 0.479 0.017 DBMET00505 0.32 0.046 DBMET00715 | DBMET00505 | |
| 0.364 | 0.008 | 0.364 | Gastrin inhibitor | 0.361 0.008 DBMET00505 0.303 0.031 DBMET00715 | ||
| 0.358 | 0.036 | 0.721 | Platelet antagonist | 0.721 0.005 DBMET00505 0.22 0.088 DBMET00715 | DBMET00505 | |
| 0.348 | 0.033 | 0.392 | Angiogenesis stimulant | 0.392 0.023 DBMET00505 0.306 0.047 DBMET00715 | DBMET00505 | |
| 0.363 | 0.068 | 0.512 | Vasodilator, peripheral | 0.512 0.026 DBMET00505 0.295 0.099 DBMET00715 | DBMET00505 | |
| 0.388 | 0.098 | 0.699 | Cyclophilin D inhibitor | 0.699 0.014 DBMET00505 0.288 0.173 DBMET00715 | DBMET00505 | |
| 0.292 | 0.002 | 0.292 | Arachidonic acid antagonist | 0.248 0.006 DBMET00505 0.284 0.003 DBMET00715 | ||
| 0.298 | 0.022 | 0.298 | Melanin inhibitor | 0.296 0.022 DBMET00505 0.254 0.028 DBMET00715 | ||
| 0.31 | 0.04 | 0.393 | DNA synthesis inhibitor | 0.393 0.022 DBMET00505 0.294 0.046 DBMET00715 | DBMET00505 | |
| 0.272 | 0.009 | 0.272 | Farnesoid X receptor antagonist | 0.173 0.033 DBMET00505 0.251 0.011 DBMET00715 | ||
| 0.282 | 0.024 | 0.282 | Neurotrophic factor enhancer | 0.275 0.026 DBMET00505 0.254 0.036 DBMET00715 | ||
| 0.303 | 0.052 | 0.303 | Transcription factor STAT3 inhibitor | 0.213 0.118 DBMET00505 0.267 0.071 DBMET00715 | ||
| 0.294 | 0.05 | 0.294 | Vasodilator | 0.211 0.096 DBMET00505 0.209 0.097 DBMET00715 | ||
| 0.251 | 0.014 | 0.251 | Antineoplastic antibiotic | 0.106 0.043 DBMET00505 0.202 0.021 DBMET00715 | ||
| 0.252 | 0.016 | 0.331 | Protein-tyrosine phosphatase 1B inhibitor | 0.331 0.009 DBMET00505 0.192 0.031 DBMET00715 | DBMET00505 | |
| 0.26 | 0.024 | 0.269 | Protein kinase stimulant | 0.269 0.022 DBMET00505 0.203 0.04 DBMET00715 | DBMET00505 | |
| 0.24 | 0.011 | 0.24 | Microtubule formation inhibitor | 0.211 0.017 DBMET00505 0.217 0.016 DBMET00715 | ||
| 0.228 | 0.002 | 0.228 | Anabolic | 0.166 0.011 DBMET00505 0.219 0.003 DBMET00715 | ||
| 0.221 | 0.007 | 0.246 | Adenylate cyclase stimulant | 0.246 0.004 DBMET00505 0.198 0.014 DBMET00715 | DBMET00505 | |
| 0.245 | 0.032 | 0.388 | Protein-tyrosine phosphatase inhibitor | 0.388 0.009 DBMET00505 0.168 0.064 DBMET00715 | DBMET00505 | |
| 0.218 | 0.005 | 0.218 | CDC25A inhibitor | 0.135 0.015 DBMET00505 0.158 0.012 DBMET00715 | ||
| 0.286 | 0.084 | 0.505 | Interleukin 2 agonist | 0.505 0.007 DBMET00505 0.277 0.092 DBMET00715 | DBMET00505 | |
| 0.204 | 0.009 | 0.204 | Transcription factor NF kappa B stimulant | 0.117 0.027 DBMET00505 0.178 0.011 DBMET00715 | ||
| 0.196 | 0.002 | 0.196 | Na+ K+ transporting ATPase inhibitor | 0.115 0.019 DBMET00505 0.178 0.003 DBMET00715 | ||
| 0.179 | 0.005 | 0.179 | Bile acid receptor antagonist | 0.135 0.011 DBMET00505 0.148 0.008 DBMET00715 | ||
| 0.188 | 0.015 | 0.188 | Pregnane X receptor agonist | 0.16 0.038 DBMET00505 0.174 0.023 DBMET00715 | ||
| 0.242 | 0.072 | 0.301 | Free radical scavenger | 0.219 0.083 DBMET00505 0.301 0.052 DBMET00715 | DBMET00715 | |
| 0.26 | 0.092 | 0.26 | Hypoxia-inducible factor 1 alpha inhibitor | 0.218 0.132 DBMET00505 0.22 0.129 DBMET00715 | ||
| 0.182 | 0.019 | 0.182 | Antineoplastic alkaloid | 0.083 0.062 DBMET00505 0.161 0.024 DBMET00715 | ||
| 0.216 | 0.053 | 0.461 | Growth hormone agonist | 0.461 0.009 DBMET00505 0.203 0.058 DBMET00715 | DBMET00505 | |
| 0.188 | 0.033 | 0.188 | Neurotrophic factor | 0.182 0.037 DBMET00715 | ||
| 0.178 | 0.026 | 0.252 | Expectorant | 0.252 0.012 DBMET00505 0.16 0.031 DBMET00715 | DBMET00505 | |
| 0.194 | 0.044 | 0.194 | Lipid peroxidase inhibitor | 0.151 0.068 DBMET00505 0.167 0.057 DBMET00715 | ||
| 0.146 | 0.008 | 0.155 | Glycine receptor antagonist | 0.155 0.006 DBMET00505 0.114 0.022 DBMET00715 | DBMET00505 | |
| 0.154 | 0.019 | 0.154 | Toll-Like receptor 4 antagonist | 0.151 0.02 DBMET00505 0.148 0.022 DBMET00715 | ||
| 0.208 | 0.079 | 0.208 | Antimitotic | 0.168 0.105 DBMET00715 | ||
| 0.136 | 0.009 | 0.225 | Glycine receptor agonist | 0.225 0.004 DBMET00505 0.098 0.022 DBMET00715 | DBMET00505 | |
| 0.165 | 0.042 | 0.248 | DNA polymerase I inhibitor | 0.248 0.017 DBMET00505 0.155 0.046 DBMET00715 | DBMET00505 | |
| 0.157 | 0.042 | 0.199 | Cyclooxygenase 3 inhibitor | 0.199 0.019 DBMET00505 0.128 0.069 DBMET00715 | DBMET00505 | |
| 0.112 | 0.004 | 0.112 | Lipocortins synthesis agonist | 0.068 0.023 DBMET00505 0.11 0.004 DBMET00715 | ||
| 0.103 | 0.003 | 0.103 | Protein 30S ribosomal subunit inhibitor | 0.071 0.005 DBMET00715 | ||
| 0.163 | 0.064 | 0.163 | Acetylcholine M1 receptor antagonist | 0.132 0.093 DBMET00505 | ||
| 0.171 | 0.072 | 0.402 | Phospholipase C inhibitor | 0.402 0.01 DBMET00505 0.145 0.116 DBMET00715 | DBMET00505 | |
| 0.102 | 0.004 | 0.102 | Farnesoid X receptor agonist | 0.055 0.012 DBMET00505 0.062 0.009 DBMET00715 | ||
| 0.11 | 0.012 | 0.11 | Androgen agonist | 0.075 0.027 DBMET00505 0.103 0.014 DBMET00715 | ||
| 0.13 | 0.038 | 0.13 | Estrogen antagonist | |||
| 0.164 | 0.072 | 0.393 | Thrombolytic | 0.393 0.012 DBMET00505 0.146 0.085 DBMET00715 | DBMET00505 | |
| 0.209 | 0.126 | 0.209 | Transcription factor STAT inhibitor | 0.204 0.133 DBMET00505 | ||
| 0.092 | 0.013 | 0.11 | Nitric oxide donor | 0.11 0.005 DBMET00505 0.076 0.026 DBMET00715 | DBMET00505 | |
| 0.089 | 0.011 | 0.089 | 5-Alpha-reductase inhibitor | 0.086 0.011 DBMET00505 0.062 0.015 DBMET00715 | ||
| 0.081 | 0.005 | 0.081 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.045 0.015 DBMET00715 | ||
| 0.079 | 0.004 | 0.079 | Microtubule stabilization | 0.055 0.022 DBMET00505 0.076 0.005 DBMET00715 | ||
| 0.083 | 0.009 | 0.083 | Acetyl-CoA transferase 2 inhibitor | 0.079 0.011 DBMET00715 | ||
| 0.123 | 0.051 | 0.242 | Mucolytic | 0.242 0.007 DBMET00505 0.112 0.062 DBMET00715 | DBMET00505 | |
| 0.105 | 0.033 | 0.158 | ATPase (Vacuolar H+) inhibitor | 0.091 0.054 DBMET00505 0.158 0.006 DBMET00715 | DBMET00715 | |
| 0.151 | 0.088 | 0.157 | Interleukin 6 antagonist | 0.157 0.079 DBMET00505 | DBMET00505 | |
| 0.127 | 0.066 | 0.127 | Papain-like protease (SARS coronavirus) inhibitor | 0.111 0.107 DBMET00715 | ||
| 0.139 | 0.079 | 0.208 | Ca2+-transporting ATPase inhibitor | 0.208 0.003 DBMET00505 0.132 0.109 DBMET00715 | DBMET00505 | |
| 0.12 | 0.061 | 0.161 | Monophenol monooxygenase inhibitor | 0.161 0.043 DBMET00505 0.104 0.073 DBMET00715 | DBMET00505 | |
| 0.081 | 0.022 | 0.159 | Prostaglandin F2 alpha antagonist | 0.159 0.004 DBMET00505 | DBMET00505 | |
| 0.21 | 0.152 | 0.465 | Immunomodulator | 0.465 0.029 DBMET00505 | DBMET00505 | |
| 0.08 | 0.022 | 0.139 | Transcription factor AP-1 inhibitor | 0.139 0.007 DBMET00715 | DBMET00715 | |
| 0.101 | 0.044 | 0.164 | Ornithine decarboxylase inhibitor | 0.164 0.008 DBMET00505 0.095 0.05 DBMET00715 | DBMET00505 | |
| 0.103 | 0.046 | 0.165 | ABCA1 expression enhancer | 0.165 0.014 DBMET00505 0.1 0.05 DBMET00715 | DBMET00505 | |
| 0.06 | 0.004 | 0.085 | Prostacyclin agonist | 0.085 0.003 DBMET00505 0.035 0.005 DBMET00715 | DBMET00505 | |
| 0.089 | 0.04 | 0.089 | T cell inhibitor | 0.086 0.046 DBMET00715 | ||
| 0.126 | 0.08 | 0.286 | Bone formation stimulant | 0.286 0.019 DBMET00505 0.11 0.095 DBMET00715 | DBMET00505 | |
| 0.057 | 0.013 | 0.057 | Parathyroid hormone antagonist | 0.054 0.016 DBMET00715 | ||
| 0.182 | 0.138 | 0.429 | Interleukin agonist | 0.429 0.015 DBMET00505 | DBMET00505 | |
| 0.049 | 0.006 | 0.049 | Estrogen-related receptor beta antagonist | |||
| 0.055 | 0.012 | 0.055 | RNA-directed RNA polymerase stimulant | 0.053 0.013 DBMET00715 | ||
| 0.088 | 0.05 | 0.103 | Inducible nitric-oxide synthase inhibitor | 0.103 0.035 DBMET00505 | DBMET00505 | |
| 0.171 | 0.133 | 0.171 | Tumour necrosis factor alpha release inhibitor | |||
| 0.051 | 0.014 | 0.051 | Squalene synthetase inhibitor | 0.047 0.015 DBMET00505 0.035 0.02 DBMET00715 | ||
| 0.046 | 0.009 | 0.079 | HMG CoA reductase inhibitor | 0.079 0.004 DBMET00505 0.043 0.012 DBMET00715 | DBMET00505 | |
| 0.063 | 0.028 | 0.097 | Protein 50S ribosomal subunit inhibitor | 0.097 0.014 DBMET00505 0.06 0.031 DBMET00715 | DBMET00505 | |
| 0.038 | 0.005 | 0.038 | Vitamin D receptor antagonist | 0.037 0.005 DBMET00715 | ||
| 0.149 | 0.116 | 0.271 | Non-steroidal antiinflammatory agent | 0.271 0.035 DBMET00505 | DBMET00505 | |
| 0.036 | 0.005 | 0.036 | Corticosteroid-like | 0.035 0.005 DBMET00715 | ||
| 0.046 | 0.015 | 0.046 | Glucose-6-phosphate dehydrogenase inhibitor | 0.045 0.016 DBMET00715 | ||
| 0.042 | 0.011 | 0.081 | Prostaglandin D2 agonist | 0.081 0.004 DBMET00505 0.033 0.019 DBMET00715 | DBMET00505 | |
| 0.064 | 0.036 | 0.064 | Heme oxygenase stimulant | 0.063 0.037 DBMET00715 | ||
| 0.176 | 0.149 | 0.176 | Streptokinase A inhibitor | |||
| 0.043 | 0.018 | 0.043 | Glucocorticoid antagonist | 0.037 0.02 DBMET00715 | ||
| 0.088 | 0.065 | 0.121 | Thioredoxin inhibitor | 0.121 0.03 DBMET00505 0.084 0.072 DBMET00715 | DBMET00505 | |
| 0.027 | 0.004 | 0.027 | Vitamin D receptor agonist | 0.021 0.006 DBMET00505 0.02 0.007 DBMET00715 | ||
| 0.095 | 0.073 | 0.095 | Estrogen receptor beta antagonist | |||
| 0.038 | 0.017 | 0.038 | Tubulin agonist | 0.038 0.018 DBMET00715 | ||
| 0.025 | 0.007 | 0.025 | Glucocorticoid agonist | 0.02 0.007 DBMET00715 | ||
| 0.052 | 0.034 | 0.052 | Estrogen agonist | 0.05 0.035 DBMET00715 | ||
| 0.02 | 0.008 | 0.029 | Telomerase stimulant | 0.029 0.003 DBMET00505 0.018 0.01 DBMET00715 | DBMET00505 | |
| 0.123 | 0.11 | 0.132 | NOS3 expression enhancer | 0.132 0.095 DBMET00505 | DBMET00505 | |
| 0.031 | 0.021 | 0.095 | Prostaglandin agonist | 0.095 0.005 DBMET00505 | DBMET00505 | |
| 0.09 | 0.085 | 0.139 | AMP-activated protein kinase stimulant | 0.139 0.036 DBMET00505 | DBMET00505 | |
| 0.011 | 0.007 | 0.041 | Thromboxane agonist | 0.041 0.003 DBMET00505 | DBMET00505 | |
| 0.05 | 0.05 | 0.096 | HIV-1 integrase (Strand Transfer) inhibitor | 0.096 0.024 DBMET00505 0.061 0.041 DBMET00715 | DBMET00505 | |
| 0.05 | 0.051 | 0.312 | Prostaglandin EP2 antagonist | 0.312 0.004 DBMET00505 | DBMET00505 | |
| 0.037 | 0.04 | 0.127 | Kainate receptor agonist | 0.127 0.002 DBMET00505 | DBMET00505 | |
| 0.055 | 0.06 | 0.094 | CDC25B inhibitor | 0.094 0.018 DBMET00505 | DBMET00505 | |
| 0.018 | 0.028 | 0.068 | Prostaglandin F2 alpha agonist | 0.068 0.003 DBMET00505 | DBMET00505 | |
| 0.037 | 0.048 | 0.042 | Potassium channel Kv1.3 blocker | 0.042 0.039 DBMET00505 | DBMET00505 | |
| 0.011 | 0.023 | 0.048 | Thromboxane A2 agonist | 0.048 0.002 DBMET00505 | DBMET00505 | |
| 0.138 | 0.151 | 0.283 | Insulin sensitizer | 0.283 0.02 DBMET00505 | DBMET00505 | |
| 0.019 | 0.032 | 0.026 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.026 0.02 DBMET00505 | DBMET00505 | |
| 0.006 | 0.02 | 0.015 | Antibiotic Macrolide-like | 0.015 0.009 DBMET00505 | DBMET00505 | |
| 0.011 | 0.029 | 0.027 | Kainate receptor 3 antagonist | 0.027 0.006 DBMET00505 | DBMET00505 | |
| 0.042 | 0.062 | 0.09 | Glucose-6-phosphate translocase inhibitor | 0.09 0.008 DBMET00715 | DBMET00715 | |
| 0.011 | 0.038 | 0.038 | Kainate receptor 5 antagonist | 0.038 0.007 DBMET00505 | DBMET00505 | |
| 0.061 | 0.089 | 0.223 | Keratolytic | 0.223 0.007 DBMET00505 | DBMET00505 | |
| 0.02 | 0.049 | 0.043 | Retinoid X gamma receptor antagonist | 0.043 0.004 DBMET00505 | DBMET00505 | |
| 0.022 | 0.051 | 0.035 | Hedgehog signaling activator | 0.035 0.007 DBMET00505 | DBMET00505 | |
| 0.061 | 0.1 | 0.079 | Estrogen receptor alpha antagonist | 0.079 0.05 DBMET00505 | DBMET00505 | |
| 0.045 | 0.087 | 0.09 | Pregnane X receptor antagonist | 0.09 0.004 DBMET00505 | DBMET00505 | |
| 0.037 | 0.079 | 0.057 | Squalene epoxidase inhibitor | 0.057 0.024 DBMET00505 | DBMET00505 | |
| 0.024 | 0.068 | 0.042 | Opioid kappa receptor agonist | 0.042 0.032 DBMET00505 | DBMET00505 | |
| 0.007 | 0.053 | 0.037 | 5-Alpha-reductase 1 inhibitor | 0.037 0.008 DBMET00505 | DBMET00505 | |
| 0.011 | 0.063 | 0.088 | Retinoid X gamma receptor agonist | 0.088 0.004 DBMET00505 | DBMET00505 | |
| 0.096 | 0.153 | 0.307 | Phospholipase A2 inhibitor | 0.307 0.012 DBMET00505 | DBMET00505 | |
| 0.009 | 0.066 | 0.083 | Retinoid X beta receptor agonist | 0.083 0.004 DBMET00505 | DBMET00505 | |
| 0.013 | 0.07 | 0.027 | Retinoic acid receptor agonist | 0.027 0.012 DBMET00505 | DBMET00505 | |
| 0.146 | 0.206 | 0.31 | Peptidyltransferase inhibitor | 0.31 0.021 DBMET00505 | DBMET00505 | |
| 0.051 | 0.113 | 0.08 | Androgen antagonist | 0.08 0.065 DBMET00505 | DBMET00505 | |
| 0.007 | 0.082 | 0.06 | Prostaglandin EP2 agonist | 0.06 0.004 DBMET00505 | DBMET00505 | |
| 0.009 | 0.087 | 0.047 | 5-Alpha-reductase 2 inhibitor | 0.047 0.007 DBMET00505 | DBMET00505 | |
| 0.13 | 0.211 | 0.331 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.331 0.016 DBMET00505 | DBMET00505 | |
| 0.004 | 0.086 | 0.033 | Ileal bile acid transport inhibitor | 0.033 0.005 DBMET00505 | DBMET00505 | |
| 0.035 | 0.122 | 0.059 | Vanilloid 2 antagonist | 0.059 0.025 DBMET00715 | DBMET00715 | |
| 0.012 | 0.103 | 0.03 | Retinoic acid gamma receptor agonist | 0.03 0.006 DBMET00505 | DBMET00505 | |
| 0.138 | 0.233 | 0.321 | RNA-directed DNA polymerase inhibitor | 0.321 0.028 DBMET00505 | DBMET00505 | |
| 0.062 | 0.162 | 0.108 | Vanilloid agonist | 0.088 0.052 DBMET00505 0.108 0.026 DBMET00715 | DBMET00715 | |
| 0.019 | 0.119 | 0.109 | Membrane dipeptidase inhibitor | 0.109 0.003 DBMET00505 | DBMET00505 | |
| 0.031 | 0.137 | 0.086 | HIV-1 integrase (3'-Processing) inhibitor | 0.086 0.031 DBMET00505 | DBMET00505 | |
| 0.026 | 0.135 | 0.062 | Aldosterone antagonist | 0.062 0.018 DBMET00505 | DBMET00505 | |
| 0.031 | 0.14 | 0.067 | Botulinum neurotoxin type A inhibitor | 0.067 0.028 DBMET00505 | DBMET00505 | |
| 0.061 | 0.176 | 0.134 | Estrogen-related receptor beta agonist | 0.134 0.006 DBMET00505 | DBMET00505 | |
| 0.044 | 0.16 | 0.254 | Glutamate (mGluR6) antagonist | 0.254 0.002 DBMET00505 | DBMET00505 | |
| 0.069 | 0.185 | 0.169 | TRPA1 agonist | 0.169 0.02 DBMET00505 | DBMET00505 | |
| 0.087 | 0.207 | 0.456 | Anesthetic general | 0.456 0.011 DBMET00505 | DBMET00505 | |
| 0.029 | 0.15 | 0.139 | Leukotriene synthesis inhibitor | 0.139 0.011 DBMET00505 0.074 0.041 DBMET00715 | DBMET00505 | |
| 0.002 | 0.133 | 0.09 | Glutamate (mGluR6) agonist | 0.09 0.002 DBMET00505 | DBMET00505 | |
| 0.12 | 0.251 | 0.547 | 5 Hydroxytryptamine release stimulant | 0.547 0.02 DBMET00505 | DBMET00505 | |
| 0.006 | 0.137 | 0.027 | Retinoic acid alpha receptor antagonist | 0.027 0.008 DBMET00505 | DBMET00505 | |
| 0.005 | 0.137 | 0.115 | Prostaglandin EP3 antagonist | 0.115 0.005 DBMET00505 | DBMET00505 | |
| 0.017 | 0.15 | 0.085 | Glutamate (mGluR3) agonist | 0.085 0.003 DBMET00505 | DBMET00505 | |
| 0.02 | 0.158 | 0.091 | Glutamate (mGluR8) antagonist | 0.091 0.003 DBMET00505 | DBMET00505 | |
| 0.004 | 0.142 | 0.058 | Prostaglandin E2 agonist | 0.058 0.005 DBMET00505 | DBMET00505 | |
| 0.064 | 0.204 | 0.276 | Photosensitizer | 0.276 0.005 DBMET00505 | DBMET00505 | |
| 0.005 | 0.158 | 0.024 | Retinoic acid receptor antagonist | 0.024 0.008 DBMET00505 | DBMET00505 | |
| 0.036 | 0.192 | 0.202 | Caspase 9 inhibitor | 0.202 0.004 DBMET00505 | DBMET00505 | |
| 0.051 | 0.211 | 0.218 | Adenylate cyclase inhibitor | 0.218 0.023 DBMET00505 | DBMET00505 | |
| 0.017 | 0.177 | 0.193 | Plasminogen activator inhibitor antagonist | 0.193 0.004 DBMET00505 | DBMET00505 | |
| 0.008 | 0.172 | 0.027 | Retinoic acid beta receptor agonist | 0.027 0.006 DBMET00505 | DBMET00505 | |
| 0.011 | 0.178 | 0.144 | ATP citrate lysase inhibitor | 0.144 0.003 DBMET00505 | DBMET00505 | |
| 0.05 | 0.218 | 0.32 | Amylase inhibitor | 0.32 0.016 DBMET00505 | DBMET00505 | |
| 0.02 | 0.191 | 0.13 | Selectin antagonist | 0.13 0.02 DBMET00505 | DBMET00505 | |
| 0.079 | 0.252 | 0.184 | Vanilloid 1 agonist | 0.184 0.017 DBMET00505 | DBMET00505 | |
| 0.048 | 0.222 | 0.189 | Alkylator | 0.189 0.03 DBMET00505 | DBMET00505 | |
| 0.022 | 0.2 | 0.261 | Glucose-6-phosphate isomerase inhibitor | 0.261 0.001 DBMET00505 | DBMET00505 | |
| 0.04 | 0.218 | 0.232 | Prolactin inhibitor | 0.232 0.005 DBMET00505 | DBMET00505 | |
| 0.014 | 0.204 | 0.063 | Retinoic acid alpha receptor agonist | 0.063 0.008 DBMET00505 | DBMET00505 | |
| 0.024 | 0.216 | 0.111 | Angiotensin-converting enzyme inhibitor | 0.111 0.008 DBMET00505 | DBMET00505 | |
| 0.09 | 0.286 | 0.203 | ATPase inhibitor | 0.203 0.034 DBMET00505 | DBMET00505 | |
| 0.008 | 0.206 | 0.044 | Retinoid X beta receptor antagonist | 0.044 0.003 DBMET00505 | DBMET00505 | |
| 0.074 | 0.284 | 0.268 | Spasmolytic | 0.268 0.084 DBMET00505 | DBMET00505 | |
| 0.007 | 0.219 | 0.505 | Fumarate hydratase inhibitor | 0.505 0.002 DBMET00505 | DBMET00505 | |
| 0.006 | 0.218 | 0.103 | Retinoid X receptor agonist | 0.103 0.004 DBMET00505 | DBMET00505 | |
| 0.014 | 0.232 | 0.05 | Liver X receptor alpha agonist | 0.05 0.019 DBMET00505 | DBMET00505 | |
| 0.008 | 0.227 | 0.12 | Retinoid X alpha receptor agonist | 0.12 0.004 DBMET00505 | DBMET00505 | |
| 0.008 | 0.234 | 0.032 | Cholesterol ester transfer protein antagonist | 0.032 0.021 DBMET00505 | DBMET00505 | |
| 0.002 | 0.23 | 0.084 | Prostaglandin EP4 agonist | 0.084 0.004 DBMET00505 | DBMET00505 | |
| 0.028 | 0.26 | 0.114 | HIV-1 integrase inhibitor | 0.114 0.018 DBMET00505 | DBMET00505 | |
| 0.071 | 0.309 | 0.166 | Antipruritic | 0.166 0.077 DBMET00505 | DBMET00505 | |
| 0.016 | 0.255 | 0.079 | Adenylate cyclase 1 inhibitor | 0.079 0.008 DBMET00505 | DBMET00505 | |
| 0.001 | 0.248 | 0.013 | Carboxypeptidase B2 inhibitor | 0.013 0.006 DBMET00505 | DBMET00505 | |
| 0.014 | 0.263 | 0.05 | Neuraminidase (Influenza A) inhibitor | 0.05 0.025 DBMET00505 | DBMET00505 | |
| 0.008 | 0.26 | 0.044 | Vanilloid 2 agonist | 0.044 0.004 DBMET00505 | DBMET00505 | |
| 0.011 | 0.268 | 0.049 | Carboxypeptidase B inhibitor | 0.049 0.007 DBMET00505 | DBMET00505 | |
| 0.006 | 0.264 | 0.043 | Leukotriene B4 receptor 2 antagonist | 0.043 0.005 DBMET00505 | DBMET00505 | |
| 0.013 | 0.273 | 0.271 | Peroxisome proliferator-activated receptor gamma agonist | 0.271 0.005 DBMET00505 | DBMET00505 | |
| 0.047 | 0.31 | 0.466 | Cell adhesion inhibitor | 0.466 0.005 DBMET00505 | DBMET00505 | |
| 0.007 | 0.277 | 0.069 | Phosphorylase inhibitor | 0.069 0.021 DBMET00505 | DBMET00505 | |
| 0.007 | 0.277 | 0.04 | LFA antagonist | 0.04 0.008 DBMET00505 | DBMET00505 | |
| 0.021 | 0.292 | 0.074 | Elastase 1 inhibitor | 0.074 0.042 DBMET00505 | DBMET00505 | |
| 0.013 | 0.284 | 0.06 | Retinoid X alpha receptor antagonist | 0.06 0.004 DBMET00505 | DBMET00505 | |
| 0.002 | 0.274 | 0.065 | Kainate receptor 1 antagonist | 0.065 0.005 DBMET00505 | DBMET00505 | |
| 0.014 | 0.289 | 0.126 | Alpha-mannosidase inhibitor | 0.126 0.004 DBMET00505 | DBMET00505 | |
| 0.012 | 0.287 | 0.416 | Phosphofructokinase-1 inhibitor | 0.416 0.003 DBMET00505 | DBMET00505 | |
| 0.017 | 0.293 | 0.06 | Neuraminidase (influenza) inhibitor | 0.06 0.053 DBMET00505 | DBMET00505 | |
| 0.005 | 0.281 | 0.031 | Isoleucine-tRNA ligase inhibitor | 0.031 0.005 DBMET00505 | DBMET00505 | |
| 0.007 | 0.285 | 0.055 | Lysophosphatidic acid receptor 1 agonist | 0.055 0.004 DBMET00505 | DBMET00505 | |
| 0.002 | 0.28 | 0.075 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.075 0.003 DBMET00505 | DBMET00505 | |
| 0.03 | 0.308 | 0.102 | Nitric-oxide synthase inhibitor | 0.102 0.056 DBMET00505 | DBMET00505 | |
| 0.014 | 0.293 | 0.07 | Retinoid X receptor antagonist | 0.07 0.004 DBMET00505 | DBMET00505 | |
| 0.017 | 0.299 | 0.05 | Vanilloid 3 antagonist | 0.05 0.009 DBMET00505 | DBMET00505 | |
| 0.061 | 0.348 | 0.461 | Insulin secretagoues | 0.461 0.005 DBMET00505 | DBMET00505 | |
| 0.022 | 0.31 | 0.097 | 5-Lipoxygenase inhibitor | 0.097 0.066 DBMET00505 | DBMET00505 | |
| 0.003 | 0.292 | 0.105 | Arginase inhibitor | 0.105 0.004 DBMET00505 | DBMET00505 | |
| 0.011 | 0.302 | 0.055 | Neuraminidase inhibitor | 0.055 0.05 DBMET00505 | DBMET00505 | |
| 0.01 | 0.303 | 0.239 | Acyl-CoA dehydrogenase inhibitor | 0.239 0.003 DBMET00505 | DBMET00505 | |
| 0.028 | 0.321 | 0.081 | Adenine nucleotide translocase inhibitor | 0.081 0.009 DBMET00505 | DBMET00505 | |
| 0.004 | 0.298 | 0.033 | Endothelin receptor antagonist | 0.033 0.015 DBMET00505 | DBMET00505 | |
| 0.036 | 0.332 | 0.809 | Alpha-N-acetylglucosaminidase inhibitor | 0.809 0.002 DBMET00505 | DBMET00505 | |
| 0.013 | 0.319 | 0.087 | Leukotriene B4 antagonist | 0.087 0.013 DBMET00505 | DBMET00505 | |
| 0.012 | 0.318 | 0.112 | Leukotriene antagonist | 0.112 0.017 DBMET00505 | DBMET00505 | |
| 0.004 | 0.317 | 0.019 | Endothelin A receptor antagonist | 0.019 0.016 DBMET00505 | DBMET00505 | |
| 0.046 | 0.369 | 0.15 | Interleukin 4 antagonist | 0.15 0.05 DBMET00505 | DBMET00505 | |
| 0.004 | 0.329 | 0.103 | Antimetabolite | 0.103 0.016 DBMET00505 | DBMET00505 | |
| 0.007 | 0.332 | 0.03 | Methylmalonyl-CoA mutase inhibitor | 0.03 0.002 DBMET00505 | DBMET00505 | |
| 0.018 | 0.348 | 0.128 | Phospholipase D inhibitor | 0.128 0.005 DBMET00505 | DBMET00505 | |
| 0.01 | 0.341 | 0.053 | Ceramide glucosyltransferase inhibitor | 0.053 0.005 DBMET00505 | DBMET00505 | |
| 0.004 | 0.338 | 0.066 | Thyroid hormone alpha antagonist | 0.066 0.004 DBMET00505 | DBMET00505 | |
| 0.003 | 0.338 | 0.267 | Free fatty acid receptor 1 agonist | 0.267 0.003 DBMET00505 | DBMET00505 | |
| 0.012 | 0.35 | 0.089 | Diacylglycerol O-acyltransferase inhibitor | 0.089 0.01 DBMET00505 | DBMET00505 | |
| 0.003 | 0.343 | 0.025 | Prostaglandin EP1 antagonist | 0.025 0.011 DBMET00505 | DBMET00505 | |
| 0.004 | 0.348 | 0.073 | Geranyltranstransferase inhibitor | 0.073 0.006 DBMET00505 | DBMET00505 | |
| 0.014 | 0.358 | 0.15 | Glutamate (mGluR8) agonist | 0.15 0.002 DBMET00505 | DBMET00505 | |
| 0.044 | 0.39 | 0.398 | Adenylate kinase inhibitor | 0.398 0.003 DBMET00505 | DBMET00505 | |
| 0.009 | 0.356 | 0.862 | Alcohol oxidase inhibitor | 0.862 0.002 DBMET00505 | DBMET00505 | |
| 0.006 | 0.356 | 0.103 | Caspase 2 inhibitor | 0.103 0.005 DBMET00505 | DBMET00505 | |
| 0.008 | 0.362 | 0.132 | Mannosidase inhibitor | 0.132 0.004 DBMET00505 | DBMET00505 | |
| 0.033 | 0.389 | 0.238 | Diuretic | 0.238 0.033 DBMET00505 | DBMET00505 | |
| 0.001 | 0.361 | 0.036 | Lysophosphatidic acid receptor 3 agonist | 0.036 0.003 DBMET00505 | DBMET00505 | |
| 0.007 | 0.367 | 0.043 | NMDA 2D receptor antagonist | 0.043 0.009 DBMET00505 | DBMET00505 | |
| 0.004 | 0.365 | 0.08 | Leukotriene B4 receptor 1 antagonist | 0.08 0.004 DBMET00505 | DBMET00505 | |
| 0.026 | 0.393 | 0.236 | Chelator | 0.236 0.018 DBMET00505 | DBMET00505 | |
| 0.004 | 0.372 | 0.097 | Ribonucleoside-diphosphate reductase inhibitor | 0.097 0.02 DBMET00505 | DBMET00505 | |
| 0.091 | 0.459 | 0.396 | Calcium channel activator | 0.396 0.026 DBMET00505 | DBMET00505 | |
| 0.017 | 0.387 | 0.074 | Heparanase inhibitor | 0.074 0.009 DBMET00505 | DBMET00505 | |
| 0.004 | 0.379 | 0.097 | Ribonucleotide reductase inhibitor | 0.097 0.021 DBMET00505 | DBMET00505 | |
| 0.006 | 0.383 | 0.101 | GABA uptake inhibitor | 0.101 0.004 DBMET00505 | DBMET00505 | |
| 0.033 | 0.412 | 0.148 | Lanosterol 14 alpha demethylase inhibitor | 0.148 0.012 DBMET00505 | DBMET00505 | |
| 0.009 | 0.393 | 0.514 | Carbamoyl phosphate synthetase inhibitor | 0.514 0.002 DBMET00505 | DBMET00505 | |
| 0.004 | 0.392 | 0.03 | Thyroid hormone alpha agonist | 0.03 0.004 DBMET00505 | DBMET00505 | |
| 0.011 | 0.4 | 0.54 | Aconitate hydratase inhibitor | 0.54 0.001 DBMET00505 | DBMET00505 | |
| 0.015 | 0.406 | 0.035 | HCV polyprotein inhibitor | 0.035 0.021 DBMET00505 | DBMET00505 | |
| 0.028 | 0.424 | 0.468 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.468 0.003 DBMET00505 | DBMET00505 | |
| 0.021 | 0.422 | 0.161 | Gastric antisecretory | 0.161 0.022 DBMET00505 | DBMET00505 | |
| 0.021 | 0.429 | 0.818 | GABA C receptor agonist | 0.818 0.001 DBMET00505 | DBMET00505 | |
| 0.015 | 0.425 | 0.039 | Calcium-independent phospholipase A2 inhibitor | 0.039 0.013 DBMET00505 | DBMET00505 | |
| 0.018 | 0.43 | 0.098 | Interferon inducer | 0.098 0.013 DBMET00505 | DBMET00505 | |
| 0.023 | 0.434 | 0.173 | Carbonic anhydrase VI inhibitor | 0.173 0.017 DBMET00505 | DBMET00505 | |
| 0.011 | 0.422 | 0.094 | VCAM antagonist | 0.094 0.004 DBMET00505 | DBMET00505 | |
| 0.011 | 0.423 | 0.092 | VCAM-1 antagonist | 0.092 0.004 DBMET00505 | DBMET00505 | |
| 0.005 | 0.419 | 0.031 | Neuraminidase (Influenza B) inhibitor | 0.031 0.004 DBMET00505 | DBMET00505 | |
| 0.021 | 0.435 | 0.542 | Glutamate dehydrogenase inhibitor | 0.542 0.003 DBMET00505 | DBMET00505 | |
| 0.005 | 0.423 | 0.177 | Aldose reductase inhibitor | 0.177 0.008 DBMET00505 | DBMET00505 | |
| 0.005 | 0.424 | 0.098 | Thromboxane A2 antagonist | 0.098 0.008 DBMET00505 | DBMET00505 | |
| 0.041 | 0.463 | 0.126 | Interleukin 12 antagonist | 0.126 0.024 DBMET00505 | DBMET00505 | |
| 0.007 | 0.434 | 0.354 | Argininosuccinate synthase inhibitor | 0.354 0.003 DBMET00505 | DBMET00505 | |
| 0.004 | 0.435 | 0.025 | Antibiotic Anthracycline-like | 0.025 0.005 DBMET00505 | DBMET00505 | |
| 0.026 | 0.457 | 0.565 | Triose-phosphate isomerase inhibitor | 0.565 0.002 DBMET00505 | DBMET00505 | |
| 0.02 | 0.457 | 0.331 | UDP-glucose 4-epimerase inhibitor | 0.331 0.009 DBMET00505 | DBMET00505 | |
| 0.1 | 0.538 | 0.515 | 5 Hydroxytryptamine uptake stimulant | 0.515 0.004 DBMET00505 | DBMET00505 | |
| 0.018 | 0.461 | 0.344 | Cystathionine beta-synthase inhibitor | 0.344 0.007 DBMET00505 | DBMET00505 | |
| 0.022 | 0.467 | 0.096 | Beta glucuronidase inhibitor | 0.096 0.077 DBMET00505 | DBMET00505 | |
| 0.006 | 0.455 | 0.108 | Thromboxane antagonist | 0.108 0.009 DBMET00505 | DBMET00505 | |
| 0.005 | 0.456 | 0.205 | Glutamate (mGluR3) antagonist | 0.205 0.003 DBMET00505 | DBMET00505 | |
| 0.011 | 0.465 | 0.062 | Cholecystokinin B agonist | 0.062 0.011 DBMET00505 | DBMET00505 | |
| 0.064 | 0.519 | 0.351 | Vasodilator, coronary | 0.351 0.055 DBMET00505 | DBMET00505 | |
| 0.004 | 0.46 | 0.137 | Prostacyclin antagonist | 0.137 0.004 DBMET00505 | DBMET00505 | |
| 0.004 | 0.462 | 0.26 | Ornithine carbamoyltransferase inhibitor | 0.26 0.005 DBMET00505 | DBMET00505 | |
| 0.009 | 0.467 | 0.045 | Cholesterol esterase inhibitor | 0.045 0.037 DBMET00505 | DBMET00505 | |
| 0.015 | 0.475 | 0.134 | Interferon agonist | 0.134 0.013 DBMET00505 | DBMET00505 | |
| 0.004 | 0.469 | 0.104 | Leukotriene D4 antagonist | 0.104 0.005 DBMET00505 | DBMET00505 | |
| 0.004 | 0.469 | 0.049 | Purinergic P2Y12 antagonist | 0.049 0.007 DBMET00505 | DBMET00505 | |
| 0.004 | 0.471 | 0.091 | Peroxisome proliferator-activated receptor alpha agonist | 0.091 0.014 DBMET00505 | DBMET00505 | |
| 0.028 | 0.495 | 0.332 | Aldehyde dehydrogenase inhibitor | 0.332 0.009 DBMET00505 | DBMET00505 | |
| 0.01 | 0.48 | 0.112 | Anesthetic local | 0.112 0.073 DBMET00505 | DBMET00505 | |
| 0.028 | 0.508 | 0.56 | Interleukin antagonist | 0.56 0.015 DBMET00505 | DBMET00505 | |
| 0.016 | 0.497 | 0.084 | Integrin alpha1beta1 antagonist | 0.084 0.003 DBMET00505 | DBMET00505 | |
| 0.018 | 0.5 | 0.113 | CD45 antagonist | 0.113 0.008 DBMET00505 | DBMET00505 | |
| 0.001 | 0.483 | 0.043 | Peroxisome proliferator-activated receptor alpha antagonist | 0.043 0.009 DBMET00505 | DBMET00505 | |
| 0.005 | 0.491 | 0.037 | Integrin beta6 antagonist | 0.037 0.002 DBMET00505 | DBMET00505 | |
| 0.021 | 0.513 | 0.12 | Proteasome inhibitor | 0.12 0.065 DBMET00505 | DBMET00505 | |
| 0.003 | 0.495 | 0.02 | Purinergic P2Y1 agonist | 0.02 0.007 DBMET00505 | DBMET00505 | |
| 0.005 | 0.503 | 0.417 | Prostaglandin antagonist | 0.417 0.004 DBMET00505 | DBMET00505 | |
| 0.026 | 0.526 | 0.06 | Transcription factor RelA inhibitor | 0.06 0.057 DBMET00505 | DBMET00505 | |
| 0.003 | 0.506 | 0.105 | Kainate receptor antagonist | 0.105 0.007 DBMET00505 | DBMET00505 | |
| 0.019 | 0.526 | 0.105 | Exportin-1 inhibitor | 0.105 0.007 DBMET00505 | DBMET00505 | |
| 0.008 | 0.518 | 0.076 | Adenosine deaminase inhibitor | 0.076 0.01 DBMET00505 | DBMET00505 | |
| 0.009 | 0.52 | 0.068 | Analgesic, opioid | 0.068 0.064 DBMET00505 | DBMET00505 | |
| 0.01 | 0.522 | 0.058 | Thymidine kinase inhibitor | 0.058 0.014 DBMET00505 | DBMET00505 | |
| 0.036 | 0.553 | 0.252 | DNA damaging | 0.252 0.079 DBMET00505 | DBMET00505 | |
| 0.006 | 0.529 | 0.374 | Biliverdin reductase inhibitor | 0.374 0.002 DBMET00505 | DBMET00505 | |
| 0.028 | 0.553 | 0.903 | Succinate dehydrogenase inhibitor | 0.903 0.002 DBMET00505 | DBMET00505 | |
| 0.001 | 0.531 | 0.036 | Aminopeptidase A inhibitor | 0.036 0.005 DBMET00505 | DBMET00505 | |
| 0.006 | 0.538 | 0.032 | Growth factor receptor-bound protein 2 antagonist | 0.032 0.031 DBMET00505 | DBMET00505 | |
| 0.047 | 0.58 | 0.479 | Toll-Like receptor 7 agonist | 0.479 0.036 DBMET00505 | DBMET00505 | |
| 0.022 | 0.559 | 0.121 | Vanilloid 4 agonist | 0.121 0.007 DBMET00505 | DBMET00505 | |
| 0.003 | 0.542 | 0.018 | Angiotensin-converting enzyme 2 inhibitor | 0.018 0.012 DBMET00505 | DBMET00505 | |
| 0.007 | 0.548 | 0.031 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.031 0.01 DBMET00505 | DBMET00505 | |
| 0.007 | 0.549 | 0.556 | Glutamate decarboxylase inhibitor | 0.556 0.002 DBMET00505 | DBMET00505 | |
| 0.027 | 0.572 | 0.106 | Phosphodiesterase 6D inhibitor | 0.106 0.042 DBMET00505 | DBMET00505 | |
| 0.045 | 0.59 | 0.485 | Toll-Like receptor agonist | 0.485 0.035 DBMET00505 | DBMET00505 | |
| 0.003 | 0.551 | 0.03 | Purinergic P2T antagonist | 0.03 0.013 DBMET00505 | DBMET00505 | |
| 0.044 | 0.594 | 0.563 | Histamine release inhibitor | 0.563 0.014 DBMET00505 | DBMET00505 | |
| 0.013 | 0.564 | 0.088 | Ryanodine receptor antagonist | 0.088 0.005 DBMET00505 | DBMET00505 | |
| 0.001 | 0.552 | 0.013 | Phosphoribosylglycinamide formyltransferase inhibitor | 0.013 0.003 DBMET00505 | DBMET00505 | |
| 0.005 | 0.558 | 0.068 | Nicotinic acid receptor agonist | 0.068 0.009 DBMET00505 | DBMET00505 | |
| 0.003 | 0.559 | 0.084 | Dopamine D5 agonist | 0.084 0.005 DBMET00505 | DBMET00505 | |
| 0.009 | 0.565 | 0.252 | Aminopeptidase I inhibitor | 0.252 0.004 DBMET00505 | DBMET00505 | |
| 0.002 | 0.561 | 0.08 | Carbonic anhydrase IV inhibitor | 0.08 0.011 DBMET00505 | DBMET00505 | |
| 0.001 | 0.564 | 0.049 | Prostaglandin H2 antagonist | 0.049 0.004 DBMET00505 | DBMET00505 | |
| 0.021 | 0.586 | 0.368 | Platelet aggregation inhibitor | 0.368 0.023 DBMET00505 | DBMET00505 | |
| 0.003 | 0.568 | 0.039 | Lysophosphatidic acid 1 receptor antagonist | 0.039 0.005 DBMET00505 | DBMET00505 | |
| 0.022 | 0.59 | 0.296 | Cell wall synthesis inhibitor | 0.296 0.01 DBMET00505 | DBMET00505 | |
| 0.007 | 0.579 | 0.131 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.131 0.025 DBMET00505 | DBMET00505 | |
| 0.019 | 0.592 | 0.17 | Interleukin 8 antagonist | 0.17 0.023 DBMET00505 | DBMET00505 | |
| 0.001 | 0.576 | 0.051 | G-protein-coupled receptor 120 agonist | 0.051 0.004 DBMET00505 | DBMET00505 | |
| 0.024 | 0.599 | 0.73 | Aldehyde oxidase inhibitor | 0.73 0.006 DBMET00505 | DBMET00505 | |
| 0.006 | 0.584 | 0.181 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.181 0.007 DBMET00505 | DBMET00505 | |
| 0.004 | 0.584 | 0.091 | Prostaglandin E2 antagonist | 0.091 0.017 DBMET00505 | DBMET00505 | |
| 0.003 | 0.582 | 0.042 | Purinergic P2Y15 antagonist | 0.042 0.006 DBMET00505 | DBMET00505 | |
| 0.003 | 0.584 | 0.074 | Guanylate cyclase inhibitor | 0.074 0.004 DBMET00505 | DBMET00505 | |
| 0.004 | 0.589 | 0.096 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.096 0.005 DBMET00505 | DBMET00505 | |
| 0.021 | 0.611 | 0.355 | NADH dehydrogenase inhibitor | 0.355 0.005 DBMET00505 | DBMET00505 | |
| 0.002 | 0.593 | 0.026 | Sodium/glucose cotransporter 2 inhibitor | 0.026 0.02 DBMET00505 | DBMET00505 | |
| 0.006 | 0.597 | 0.109 | Lysophosphatidic acid 3 receptor antagonist | 0.109 0.004 DBMET00505 | DBMET00505 | |
| 0.035 | 0.627 | 0.204 | Glutamate release inhibitor | 0.204 0.005 DBMET00505 | DBMET00505 | |
| 0.008 | 0.602 | 0.07 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.07 0.021 DBMET00505 | DBMET00505 | |
| 0.01 | 0.605 | 0.13 | Glutamate (mGluR group III) antagonist | 0.13 0.004 DBMET00505 | DBMET00505 | |
| 0.003 | 0.603 | 0.017 | Endothelin B receptor antagonist | 0.017 0.014 DBMET00505 | DBMET00505 | |
| 0.005 | 0.608 | 0.069 | Nicotinic alpha4beta2 receptor antagonist | 0.069 0.063 DBMET00505 | DBMET00505 | |
| 0.005 | 0.612 | 0.042 | Sphingosine kinase 1 inhibitor | 0.042 0.027 DBMET00505 | DBMET00505 | |
| 0.005 | 0.614 | 0.066 | Sphingosine kinase inhibitor | 0.066 0.029 DBMET00505 | DBMET00505 | |
| 0.001 | 0.617 | 0.064 | Uridine phosphorylase inhibitor | 0.064 0.005 DBMET00505 | DBMET00505 | |
| 0.004 | 0.623 | 0.132 | Toll-Like receptor 2 agonist | 0.132 0.012 DBMET00505 | DBMET00505 | |
| 0.003 | 0.623 | 0.024 | Sodium/glucose cotransporter inhibitor | 0.024 0.022 DBMET00505 | DBMET00505 | |
| 0.003 | 0.631 | 0.021 | CXC chemokine 5 receptor antagonist | 0.021 0.007 DBMET00505 | DBMET00505 | |
| 0.005 | 0.636 | 0.027 | ICAM 1 antagonist | 0.027 0.009 DBMET00505 | DBMET00505 | |
| 0.017 | 0.651 | 0.258 | HIV-1 integrase (Overall Integration) inhibitor | 0.258 0.005 DBMET00505 | DBMET00505 | |
| 0.014 | 0.656 | 0.227 | Lipoxygenase inhibitor | 0.227 0.116 DBMET00505 | DBMET00505 | |
| 0.002 | 0.644 | 0.021 | Estrogen-related receptor gamma agonist | 0.021 0.009 DBMET00505 | DBMET00505 | |
| 0.004 | 0.647 | 0.058 | Prolyl endopeptidase inhibitor | 0.058 0.026 DBMET00505 | DBMET00505 | |
| 0.013 | 0.658 | 0.235 | Toll-Like receptor 2 antagonist | 0.235 0.012 DBMET00505 | DBMET00505 | |
| 0.006 | 0.651 | 0.022 | Tryptophan hydroxylase 1 inhibitor | 0.022 0.005 DBMET00505 | DBMET00505 | |
| 0.014 | 0.66 | 0.135 | Xanthine oxidase inhibitor | 0.135 0.04 DBMET00505 | DBMET00505 | |
| 0.003 | 0.649 | 0.237 | Prostaglandin D2 antagonist | 0.237 0.004 DBMET00505 | DBMET00505 | |
| 0.017 | 0.664 | 0.111 | DNA helicase inhibitor | 0.111 0.004 DBMET00505 | DBMET00505 | |
| 0.003 | 0.651 | 0.103 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.103 0.016 DBMET00505 | DBMET00505 | |
| 0.002 | 0.65 | 0.047 | Glutamate (mGluR group II) antagonist | 0.047 0.018 DBMET00505 | DBMET00505 | |
| 0.001 | 0.649 | 0.074 | Carbonic anhydrase VIII inhibitor | 0.074 0.002 DBMET00505 | DBMET00505 | |
| 0.001 | 0.649 | 0.074 | Carbonic anhydrase X inhibitor | 0.074 0.002 DBMET00505 | DBMET00505 | |
| 0.009 | 0.662 | 0.438 | Cell adhesion molecule inhibitor | 0.438 0.004 DBMET00505 | DBMET00505 | |
| 0.021 | 0.675 | 0.265 | Cyclic AMP phosphodiesterase inhibitor | 0.265 0.057 DBMET00505 | DBMET00505 | |
| 0.054 | 0.71 | 0.651 | Tyrosine 3 hydroxylase inhibitor | 0.651 0.003 DBMET00505 | DBMET00505 | |
| 0.005 | 0.662 | 0.064 | HCV NS3/NS4A protease inhibitor | 0.064 0.018 DBMET00505 | DBMET00505 | |
| 0.002 | 0.663 | 0.048 | Neutral endopeptidase inhibitor | 0.048 0.008 DBMET00505 | DBMET00505 | |
| 0.002 | 0.664 | 0.112 | Lysine carboxypeptidase inhibitor | 0.112 0.003 DBMET00505 | DBMET00505 | |
| 0.005 | 0.672 | 0.104 | Thromboxane synthase inhibitor | 0.104 0.006 DBMET00505 | DBMET00505 | |
| 0.016 | 0.683 | 0.091 | mTOR complex 2 inhibitor | 0.091 0.045 DBMET00505 | DBMET00505 | |
| 0.007 | 0.683 | 0.094 | Calcium antagonist | 0.094 0.052 DBMET00505 | DBMET00505 | |
| 0.009 | 0.685 | 0.046 | Neurotensin receptor antagonist | 0.046 0.031 DBMET00505 | DBMET00505 | |
| 0.009 | 0.688 | 0.353 | GABA C receptor antagonist | 0.353 0.004 DBMET00505 | DBMET00505 | |
| 0.004 | 0.685 | 0.366 | Catalase inhibitor | 0.366 0.004 DBMET00505 | DBMET00505 | |
| 0.012 | 0.693 | 0.061 | Topoisomerase II beta inhibitor | 0.061 0.021 DBMET00505 | DBMET00505 | |
| 0.004 | 0.686 | 0.075 | Epoxide hydrolase inhibitor | 0.075 0.047 DBMET00505 | DBMET00505 | |
| 0.016 | 0.698 | 0.229 | Carbonic anhydrase III inhibitor | 0.229 0.012 DBMET00505 | DBMET00505 | |
| 0.006 | 0.688 | 0.232 | NMDA receptor agonist | 0.232 0.004 DBMET00505 | DBMET00505 | |
| 0.026 | 0.709 | 0.177 | CF transmembrane conductance regulator agonist | 0.177 0.039 DBMET00505 | DBMET00505 | |
| 0.004 | 0.687 | 0.063 | Leukotriene C4 antagonist | 0.063 0.005 DBMET00505 | DBMET00505 | |
| 0.002 | 0.685 | 0.045 | Nicotinic acid receptor 2 antagonist | 0.045 0.004 DBMET00505 | DBMET00505 | |
| 0.014 | 0.7 | 0.073 | Chymotrypsin inhibitor | 0.073 0.064 DBMET00505 | DBMET00505 | |
| 0.012 | 0.698 | 0.067 | Bombesin 2 receptor antagonist | 0.067 0.021 DBMET00505 | DBMET00505 | |
| 0.009 | 0.696 | 0.215 | Uric acid excretion stimulant | 0.215 0.011 DBMET00505 | DBMET00505 | |
| 0.004 | 0.691 | 0.028 | Liver X receptor alpha antagonist | 0.028 0.023 DBMET00505 | DBMET00505 | |
| 0.009 | 0.697 | 0.603 | Ferrochelatase inhibitor | 0.603 0.002 DBMET00505 | DBMET00505 | |
| 0.005 | 0.696 | 0.063 | p53 inhibitor | 0.063 0.007 DBMET00505 | DBMET00505 | |
| 0.008 | 0.699 | 0.089 | Protease 3C (Human rhinovirus) inhibitor | 0.089 0.021 DBMET00505 | DBMET00505 | |
| 0.007 | 0.7 | 0.128 | Glutamate (mGluR7) antagonist | 0.128 0.004 DBMET00505 | DBMET00505 | |
| 0.005 | 0.698 | 0.337 | Psychostimulant | 0.337 0.034 DBMET00505 | DBMET00505 | |
| 0.003 | 0.697 | 0.331 | GP IIb/IIIa receptor antagonist | 0.331 0.004 DBMET00505 | DBMET00505 | |
| 0.013 | 0.708 | 0.296 | DNA methyltransferase I inhibitor | 0.296 0.028 DBMET00505 | DBMET00505 | |
| 0.006 | 0.702 | 0.098 | Peroxisome proliferator-activated receptor gamma antagonist | 0.098 0.017 DBMET00505 | DBMET00505 | |
| 0.011 | 0.709 | 0.053 | Nicotinic alpha3beta2 receptor antagonist | 0.053 0.037 DBMET00505 | DBMET00505 | |
| 0.027 | 0.725 | 0.539 | Superoxide dismutase inhibitor | 0.539 0.01 DBMET00505 | DBMET00505 | |
| 0.012 | 0.712 | 0.28 | Aminopeptidase B inhibitor | 0.28 0.01 DBMET00505 | DBMET00505 | |
| 0 | 0.701 | 0.016 | Integrin alpha5beta6 antagonist | 0.016 0.002 DBMET00505 | DBMET00505 | |
| 0.018 | 0.719 | 0.138 | Histone deacetylase SIRT1 inhibitor | 0.138 0.072 DBMET00505 | DBMET00505 | |
| 0.008 | 0.71 | 0.139 | Mediator release inhibitor | 0.139 0.034 DBMET00505 | DBMET00505 | |
| 0.015 | 0.718 | 0.313 | Interleukin 1 antagonist | 0.313 0.01 DBMET00505 | DBMET00505 | |
| 0.002 | 0.707 | 0.017 | Calcium-dependent phospholipase A2 inhibitor | 0.017 0.005 DBMET00505 | DBMET00505 | |
| 0.008 | 0.714 | 0.211 | GABA B receptor agonist | 0.211 0.003 DBMET00505 | DBMET00505 | |
| 0.003 | 0.709 | 0.11 | NMDA 2C receptor antagonist | 0.11 0.013 DBMET00505 | DBMET00505 | |
| 0.002 | 0.709 | 0.026 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.026 0.006 DBMET00505 | DBMET00505 | |
| 0.004 | 0.712 | 0.088 | Leukotriene C antagonist | 0.088 0.005 DBMET00505 | DBMET00505 | |
| 0.011 | 0.718 | 0.156 | Glutathione S-transferase inhibitor | 0.156 0.011 DBMET00505 | DBMET00505 | |
| 0.009 | 0.718 | 0.256 | Anticoagulant | 0.256 0.037 DBMET00505 | DBMET00505 | |
| 0.004 | 0.715 | 0.216 | Peroxisome proliferator-activated receptor delta antagonist | 0.216 0.004 DBMET00505 | DBMET00505 | |
| 0.003 | 0.715 | 0.075 | Prostaglandin-E synthase inhibitor | 0.075 0.043 DBMET00505 | DBMET00505 | |
| 0.004 | 0.717 | 0.735 | Porphobilinogen synthase inhibitor | 0.735 0.002 DBMET00505 | DBMET00505 | |
| 0.006 | 0.72 | 0.272 | Sphingosine 1-phosphate receptor 5 agonist | 0.272 0.004 DBMET00505 | DBMET00505 | |
| 0.002 | 0.717 | 0.054 | Prostaglandin EP4 antagonist | 0.054 0.008 DBMET00505 | DBMET00505 | |
| 0.006 | 0.726 | 0.12 | Beta amyloid protein antagonist | 0.12 0.067 DBMET00505 | DBMET00505 | |
| 0.001 | 0.721 | 0.028 | Nicotinic acid receptor 1 antagonist | 0.028 0.005 DBMET00505 | DBMET00505 | |
| 0.013 | 0.734 | 0.071 | Potassium channel large-conductance Ca-activated activator | 0.071 0.043 DBMET00505 | DBMET00505 | |
| 0.001 | 0.725 | 0.07 | Peroxisome proliferator-activated receptor delta agonist | 0.07 0.009 DBMET00505 | DBMET00505 | |
| 0.002 | 0.726 | 0.048 | Liver X receptor beta antagonist | 0.048 0.009 DBMET00505 | DBMET00505 | |
| 0.009 | 0.737 | 0.084 | Sirtuin 1 inhibitor | 0.084 0.032 DBMET00505 | DBMET00505 | |
| 0.002 | 0.734 | 0.099 | NMDA receptor subunit 3A antagonist | 0.099 0.009 DBMET00505 | DBMET00505 | |
| 0.003 | 0.735 | 0.022 | Geranylgeranyltransferase inhibitor | 0.022 0.016 DBMET00505 | DBMET00505 | |
| 0.014 | 0.748 | 0.285 | DNA methylase inhibitor | 0.285 0.033 DBMET00505 | DBMET00505 | |
| 0.008 | 0.745 | 0.159 | Cathepsin G inhibitor | 0.159 0.02 DBMET00505 | DBMET00505 | |
| 0.003 | 0.741 | 0.05 | Cholecystokinin A antagonist | 0.05 0.019 DBMET00505 | DBMET00505 | |
| 0.005 | 0.747 | 0.275 | GABA aminotransferase inhibitor | 0.275 0.004 DBMET00505 | DBMET00505 | |
| 0.009 | 0.752 | 0.081 | Dihydroorotate oxidase inhibitor | 0.081 0.01 DBMET00505 | DBMET00505 | |
| 0.006 | 0.751 | 0.08 | CYP2A6 inhibitor | 0.08 0.049 DBMET00505 | DBMET00505 | |
| 0.011 | 0.76 | 0.238 | DOPA decarboxylase inhibitor | 0.238 0.004 DBMET00505 | DBMET00505 | |
| 0.002 | 0.756 | 0.263 | Integrin beta3 antagonist | 0.263 0.004 DBMET00505 | DBMET00505 | |
| 0.008 | 0.763 | 0.149 | Carbonic anhydrase XIII inhibitor | 0.149 0.022 DBMET00505 | DBMET00505 | |
| 0.008 | 0.764 | 0.134 | Glutamate (mGluR4) antagonist | 0.134 0.004 DBMET00505 | DBMET00505 | |
| 0.003 | 0.761 | 0.139 | Integrin alphaVbeta1 antagonist | 0.139 0.003 DBMET00505 | DBMET00505 | |
| 0.01 | 0.77 | 0.167 | Purinergic P2X1 antagonist | 0.167 0.005 DBMET00505 | DBMET00505 | |
| 0.003 | 0.765 | 0.08 | GABA B receptor antagonist | 0.08 0.006 DBMET00505 | DBMET00505 | |
| 0.002 | 0.764 | 0.115 | NMDA receptor subunit 3B antagonist | 0.115 0.009 DBMET00505 | DBMET00505 | |
| 0.006 | 0.768 | 0.119 | GABA receptor agonist | 0.119 0.058 DBMET00505 | DBMET00505 | |
| 0.049 | 0.813 | 0.276 | Nitric-oxide synthase stimulant | 0.276 0.019 DBMET00505 | DBMET00505 | |
| 0.021 | 0.787 | 0.068 | Calcium channel P-type blocker | 0.068 0.032 DBMET00505 | DBMET00505 | |
| 0.003 | 0.771 | 0.149 | Integrin beta5 antagonist | 0.149 0.004 DBMET00505 | DBMET00505 | |
| 0.015 | 0.784 | 0.128 | NADPH oxidase inhibitor | 0.128 0.074 DBMET00505 | DBMET00505 | |
| 0.011 | 0.78 | 0.138 | Antibacterial (Helicobacter pylori) | 0.138 0.057 DBMET00505 | DBMET00505 | |
| 0.003 | 0.773 | 0.066 | Cholecystokinin antagonist | 0.066 0.016 DBMET00505 | DBMET00505 | |
| 0.007 | 0.777 | 0.301 | Creatine kinase inhibitor | 0.301 0.004 DBMET00505 | DBMET00505 | |
| 0.003 | 0.774 | 0.173 | Integrin alphaVbeta3 antagonist | 0.173 0.003 DBMET00505 | DBMET00505 | |
| 0.001 | 0.773 | 0.105 | Kynurenine 3 monooxygenase inhibitor | 0.105 0.004 DBMET00505 | DBMET00505 | |
| 0.008 | 0.78 | 0.054 | Heme oxygenase inhibitor | 0.054 0.009 DBMET00505 | DBMET00505 | |
| 0 | 0.773 | 0.014 | Thyroid hormone beta agonist | 0.014 0.004 DBMET00505 | DBMET00505 | |
| 0.002 | 0.775 | 0.074 | Carbonic anhydrase inhibitor | 0.074 0.038 DBMET00505 | DBMET00505 | |
| 0.003 | 0.777 | 0.07 | Sphingosine 1-phosphate receptor 3 agonist | 0.07 0.009 DBMET00505 | DBMET00505 | |
| 0.003 | 0.779 | 0.056 | Calcitonin receptor agonist | 0.056 0.015 DBMET00505 | DBMET00505 | |
| 0.005 | 0.784 | 0.107 | AICAR transformylase inhibitor | 0.107 0.004 DBMET00505 | DBMET00505 | |
| 0.01 | 0.789 | 0.28 | Electrolyte absorption antagonist | 0.28 0.004 DBMET00505 | DBMET00505 | |
| 0.001 | 0.782 | 0.088 | Free fatty acid receptor 1 antagonist | 0.088 0.004 DBMET00505 | DBMET00505 | |
| 0.003 | 0.785 | 0.372 | Histidine decarboxylase inhibitor | 0.372 0.004 DBMET00505 | DBMET00505 | |
| 0.001 | 0.786 | 0.059 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.059 0.007 DBMET00505 | DBMET00505 | |
| 0.001 | 0.789 | 0.04 | Methionyl aminopeptidase 1 inhibitor | 0.04 0.012 DBMET00505 | DBMET00505 | |
| 0.002 | 0.789 | 0.033 | Liver X receptor beta agonist | 0.033 0.023 DBMET00505 | DBMET00505 | |
| 0.003 | 0.791 | 0.057 | Oxytocin agonist | 0.057 0.019 DBMET00505 | DBMET00505 | |
| 0.006 | 0.794 | 0.08 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.08 0.004 DBMET00505 | DBMET00505 | |
| 0.002 | 0.792 | 0.053 | Thyroid hormone agonist | 0.053 0.004 DBMET00505 | DBMET00505 | |
| 0.011 | 0.801 | 0.176 | Hemostatic | 0.176 0.045 DBMET00505 | DBMET00505 | |
| 0.003 | 0.794 | 0.03 | Caspase 8 inhibitor | 0.03 0.005 DBMET00505 | DBMET00505 | |
| 0.063 | 0.857 | 0.406 | Calcium channel L-type activator | 0.406 0.077 DBMET00505 | DBMET00505 | |
| 0.003 | 0.8 | 0.114 | NMDA receptor antagonist | 0.114 0.038 DBMET00505 | DBMET00505 | |
| 0.006 | 0.807 | 0.101 | Aminoacyl-tRNA synthetase inhibitor | 0.101 0.044 DBMET00505 | DBMET00505 | |
| 0.002 | 0.804 | 0.04 | Cholecystokinin B antagonist | 0.04 0.014 DBMET00505 | DBMET00505 | |
| 0.003 | 0.805 | 0.411 | Phenylalanine 4-hydroxylase inhibitor | 0.411 0.003 DBMET00505 | DBMET00505 | |
| 0.002 | 0.811 | 0.086 | NMDA 2A receptor antagonist | 0.086 0.018 DBMET00505 | DBMET00505 | |
| 0.004 | 0.814 | 0.135 | Macrophage migration inhibitory factor inhibitor | 0.135 0.02 DBMET00505 | DBMET00505 | |
| 0.003 | 0.814 | 0.028 | Urotensin II agonist | 0.028 0.018 DBMET00505 | DBMET00505 | |
| 0.001 | 0.812 | 0.012 | Purine nucleoside phosphorylase inhibitor | 0.012 0.008 DBMET00505 | DBMET00505 | |
| 0.001 | 0.812 | 0.015 | Integrin beta2 antagonist | 0.015 0.006 DBMET00505 | DBMET00505 | |
| 0.003 | 0.817 | 0.064 | Beta 2 adrenoreceptor agonist | 0.064 0.035 DBMET00505 | DBMET00505 | |
| 0.003 | 0.818 | 0.038 | Estrogen-related receptor gamma antagonist | 0.038 0.006 DBMET00505 | DBMET00505 | |
| 0.008 | 0.826 | 0.224 | 15-Lipoxygenase inhibitor | 0.224 0.187 DBMET00505 | DBMET00505 | |
| 0.004 | 0.823 | 0.116 | Integrin alpha5beta1 antagonist | 0.116 0.005 DBMET00505 | DBMET00505 | |
| 0.002 | 0.822 | 0.139 | NMDA receptor glycine site agonist | 0.139 0.005 DBMET00505 | DBMET00505 | |
| 0.003 | 0.823 | 0.084 | Complement C3a chemotactic receptor antagonist | 0.084 0.013 DBMET00505 | DBMET00505 | |
| 0.003 | 0.825 | 0.026 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.026 0.022 DBMET00505 | DBMET00505 | |
| 0.007 | 0.829 | 0.153 | Antiamyloidogenic | 0.153 0.144 DBMET00505 | DBMET00505 | |
| 0.003 | 0.827 | 0.063 | Sphingosine kinase 2 inhibitor | 0.063 0.029 DBMET00505 | DBMET00505 | |
| 0 | 0.825 | 0.029 | Carbonic anhydrase XI inhibitor | 0.029 0.003 DBMET00505 | DBMET00505 | |
| 0.002 | 0.827 | 0.075 | Integrin beta7 antagonist | 0.075 0.005 DBMET00505 | DBMET00505 | |
| 0.002 | 0.828 | 0.07 | Carbonic anhydrase XIV inhibitor | 0.07 0.02 DBMET00505 | DBMET00505 | |
| 0.002 | 0.828 | 0.08 | Lysophosphatidic acid 2 receptor antagonist | 0.08 0.005 DBMET00505 | DBMET00505 | |
| 0.003 | 0.83 | 0.105 | AMPA 4 receptor antagonist | 0.105 0.005 DBMET00505 | DBMET00505 | |
| 0.004 | 0.831 | 0.061 | Tryptophan 5 hydroxylase inhibitor | 0.061 0.004 DBMET00505 | DBMET00505 | |
| 0.004 | 0.833 | 0.129 | Macrophage elastase inhibitor | 0.129 0.006 DBMET00505 | DBMET00505 | |
| 0.002 | 0.834 | 0.07 | Xanthine dehydrogenase inhibitor | 0.07 0.031 DBMET00505 | DBMET00505 | |
| 0.002 | 0.835 | 0.048 | Leukocyte elastase inhibitor | 0.048 0.025 DBMET00505 | DBMET00505 | |
| 0.002 | 0.836 | 0.056 | Matrix metalloproteinase 1 inhibitor | 0.056 0.034 DBMET00505 | DBMET00505 | |
| 0.006 | 0.843 | 0.189 | Caspase 3 inhibitor | 0.189 0.012 DBMET00505 | DBMET00505 | |
| 0.003 | 0.84 | 0.111 | Carbonic anhydrase VA inhibitor | 0.111 0.021 DBMET00505 | DBMET00505 | |
| 0.006 | 0.844 | 0.182 | Dual specificity phosphatase 3 inhibitor | 0.182 0.072 DBMET00505 | DBMET00505 | |
| 0.009 | 0.847 | 0.098 | MAP kinase kinase 7 inhibitor | 0.098 0.014 DBMET00505 | DBMET00505 | |
| 0.009 | 0.847 | 0.149 | Granulocyte macrophage colony stimulating factor agonist | 0.149 0.005 DBMET00505 | DBMET00505 | |
| 0.009 | 0.848 | 0.127 | Acetylcholine release stimulant | 0.127 0.038 DBMET00505 | DBMET00505 | |
| 0.003 | 0.844 | 0.057 | Protocollagen prolyl hydroxylase inhibitor | 0.057 0.005 DBMET00505 | DBMET00505 | |
| 0.008 | 0.849 | 0.133 | Sphingomyelinase inhibitor | 0.133 0.033 DBMET00505 | DBMET00505 | |
| 0.003 | 0.844 | 0.095 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.095 0.017 DBMET00505 | DBMET00505 | |
| 0.001 | 0.843 | 0.073 | Phosphoglycerate kinase inhibitor | 0.073 0.009 DBMET00505 | DBMET00505 | |
| 0.002 | 0.844 | 0.058 | Dihydroorotase inhibitor | 0.058 0.017 DBMET00505 | DBMET00505 | |
| 0.002 | 0.844 | 0.053 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.053 0.008 DBMET00505 | DBMET00505 | |
| 0.008 | 0.851 | 0.19 | Dual specificity phosphatase inhibitor | 0.19 0.06 DBMET00505 | DBMET00505 | |
| 0.008 | 0.853 | 0.068 | Carnitine palmitoyltransferase 1B inhibitor | 0.068 0.012 DBMET00505 | DBMET00505 | |
| 0 | 0.845 | 0.02 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.02 0.004 DBMET00505 | DBMET00505 | |
| 0.002 | 0.847 | 0.129 | VLA-4 antagonist | 0.129 0.004 DBMET00505 | DBMET00505 | |
| 0.001 | 0.847 | 0.15 | Glutamate (mGluR1a) agonist | 0.15 0.003 DBMET00505 | DBMET00505 | |
| 0.019 | 0.866 | 0.583 | 5 Hydroxytryptamine release inhibitor | 0.583 0.013 DBMET00505 | DBMET00505 | |
| 0.001 | 0.848 | 0.103 | Carbonic anhydrase VB inhibitor | 0.103 0.015 DBMET00505 | DBMET00505 | |
| 0.011 | 0.858 | 0.588 | Peroxidase inhibitor | 0.588 0.005 DBMET00505 | DBMET00505 | |
| 0.002 | 0.85 | 0.117 | Carbonic anhydrase V inhibitor | 0.117 0.022 DBMET00505 | DBMET00505 | |
| 0.003 | 0.851 | 0.24 | Vitronectin receptor antagonist | 0.24 0.004 DBMET00505 | DBMET00505 | |
| 0.006 | 0.856 | 0.28 | GABA C receptor rho-1 antagonist | 0.28 0.004 DBMET00505 | DBMET00505 | |
| 0.001 | 0.853 | 0.071 | Sphingosine 1-phosphate receptor 1 agonist | 0.071 0.008 DBMET00505 | DBMET00505 | |
| 0.029 | 0.882 | 0.186 | Heat shock protein 70 antagonist | 0.186 0.009 DBMET00505 | DBMET00505 | |
| 0.018 | 0.872 | 0.591 | GABA C receptor rho-3 antagonist | 0.591 0.008 DBMET00505 | DBMET00505 | |
| 0.004 | 0.859 | 0.092 | Maillard reaction inhibitor | 0.092 0.02 DBMET00505 | DBMET00505 | |
| 0.002 | 0.859 | 0.073 | Purinergic P2Y antagonist | 0.073 0.014 DBMET00505 | DBMET00505 | |
| 0.001 | 0.858 | 0.086 | Urate transporter 1 inhibitor | 0.086 0.007 DBMET00505 | DBMET00505 | |
| 0.003 | 0.862 | 0.289 | Alcohol dehydrogenase inhibitor | 0.289 0.005 DBMET00505 | DBMET00505 | |
| 0.004 | 0.865 | 0.053 | Fatty acid synthase inhibitor | 0.053 0.046 DBMET00505 | DBMET00505 | |
| 0.008 | 0.871 | 0.178 | Sphingosine 1-phosphate receptor 4 antagonist | 0.178 0.015 DBMET00505 | DBMET00505 | |
| 0.001 | 0.864 | 0.078 | Dihydropteroate synthase inhibitor | 0.078 0.007 DBMET00505 | DBMET00505 | |
| 0.001 | 0.866 | 0.019 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.019 0.014 DBMET00505 | DBMET00505 | |
| 0.005 | 0.872 | 0.13 | Toll-Like receptor antagonist | 0.13 0.072 DBMET00505 | DBMET00505 | |
| 0.002 | 0.87 | 0.091 | Protein kinase C zeta inhibitor | 0.091 0.064 DBMET00505 | DBMET00505 | |
| 0.002 | 0.87 | 0.094 | Matrix metalloproteinase inhibitor | 0.094 0.029 DBMET00505 | DBMET00505 | |
| 0.001 | 0.87 | 0.042 | Epoxide hydrolase 1 inhibitor | 0.042 0.01 DBMET00505 | DBMET00505 | |
| 0.004 | 0.876 | 0.097 | Glucagon-like peptide 1 agonist | 0.097 0.024 DBMET00505 | DBMET00505 | |
| 0.003 | 0.876 | 0.058 | Glucosylceramidase inhibitor | 0.058 0.034 DBMET00505 | DBMET00505 | |
| 0.001 | 0.874 | 0.035 | NMDA receptor glycine site antagonist | 0.035 0.01 DBMET00505 | DBMET00505 | |
| 0.001 | 0.875 | 0.008 | Free fatty acid receptor 2 antagonist | 0.008 0.006 DBMET00505 | DBMET00505 | |
| 0.002 | 0.877 | 0.109 | Glutamate (mGluR1) agonist | 0.109 0.004 DBMET00505 | DBMET00505 | |
| 0.005 | 0.881 | 0.053 | Erythropoietin receptor agonist | 0.053 0.02 DBMET00505 | DBMET00505 | |
| 0.002 | 0.878 | 0.05 | Glutamate (mGluR1) antagonist | 0.05 0.048 DBMET00505 | DBMET00505 | |
| 0.012 | 0.891 | 0.196 | Hexokinase inhibitor | 0.196 0.037 DBMET00505 | DBMET00505 | |
| 0.003 | 0.882 | 0.047 | Potassium channel (ATP-sensitive) activator | 0.047 0.036 DBMET00505 | DBMET00505 | |
| 0.003 | 0.883 | 0.049 | Potassium channel (Inward rectifier) activator | 0.049 0.037 DBMET00505 | DBMET00505 | |
| 0.004 | 0.884 | 0.216 | 12-Lipoxygenase inhibitor | 0.216 0.135 DBMET00505 | DBMET00505 | |
| 0.002 | 0.884 | 0.077 | Metalloproteinase-9 inhibitor | 0.077 0.047 DBMET00505 | DBMET00505 | |
| 0.01 | 0.893 | 0.12 | D-Ala-D-Ala ligase inhibitor | 0.12 0.013 DBMET00505 | DBMET00505 | |
| 0.006 | 0.89 | 0.145 | Potassium channel (Ca-activated) activator | 0.145 0.029 DBMET00505 | DBMET00505 | |
| 0.015 | 0.9 | 0.151 | Hematopoietic | 0.151 0.015 DBMET00505 | DBMET00505 | |
| 0.006 | 0.891 | 0.108 | MDM2 inhibitor | 0.108 0.005 DBMET00505 | DBMET00505 | |
| 0.003 | 0.888 | 0.068 | Dopamine beta hydroxylase inhibitor | 0.068 0.009 DBMET00505 | DBMET00505 | |
| 0.008 | 0.893 | 0.27 | GABA C receptor rho-2 antagonist | 0.27 0.008 DBMET00505 | DBMET00505 | |
| 0.022 | 0.907 | 0.254 | Folate antagonist | 0.254 0.005 DBMET00505 | DBMET00505 | |
| 0.001 | 0.887 | 0.105 | Kainate receptor 2 antagonist | 0.105 0.004 DBMET00505 | DBMET00505 | |
| 0.005 | 0.892 | 0.19 | Cathepsin H inhibitor | 0.19 0.025 DBMET00505 | DBMET00505 | |
| 0.001 | 0.888 | 0.022 | Integrin alphaVbeta6 antagonist | 0.022 0.005 DBMET00505 | DBMET00505 | |
| 0.001 | 0.89 | 0.062 | Acetylcholine M5 receptor agonist | 0.062 0.053 DBMET00505 | DBMET00505 | |
| 0.002 | 0.89 | 0.077 | Glycine transporter 2 inhibitor | 0.077 0.018 DBMET00505 | DBMET00505 | |
| 0.002 | 0.891 | 0.04 | Kainate receptor 4 antagonist | 0.04 0.009 DBMET00505 | DBMET00505 | |
| 0.006 | 0.895 | 0.196 | Thyroid hormone antagonist | 0.196 0.166 DBMET00505 | DBMET00505 | |
| 0.001 | 0.891 | 0.028 | Thymidine phosphorylase inhibitor | 0.028 0.015 DBMET00505 | DBMET00505 | |
| 0.003 | 0.893 | 0.061 | AMPA 2 receptor antagonist | 0.061 0.009 DBMET00505 | DBMET00505 | |
| 0.001 | 0.893 | 0.055 | Metalloproteinase-3 inhibitor | 0.055 0.027 DBMET00505 | DBMET00505 | |
| 0.002 | 0.895 | 0.069 | Beta adrenoreceptor antagonist | 0.069 0.04 DBMET00505 | DBMET00505 | |
| 0.003 | 0.898 | 0.054 | Cytokine production stimulant | 0.054 0.02 DBMET00505 | DBMET00505 | |
| 0.029 | 0.926 | 0.469 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.469 0.05 DBMET00505 | DBMET00505 | |
| 0.004 | 0.902 | 0.204 | Sphingosine 1-phosphate receptor 5 antagonist | 0.204 0.01 DBMET00505 | DBMET00505 | |
| 0.002 | 0.901 | 0.12 | Cytidine deaminase inhibitor | 0.12 0.1 DBMET00505 | DBMET00505 | |
| 0.003 | 0.903 | 0.048 | Caspase 6 inhibitor | 0.048 0.005 DBMET00505 | DBMET00505 | |
| 0.002 | 0.903 | 0.034 | Melatonin receptor 1A agonist | 0.034 0.022 DBMET00505 | DBMET00505 | |
| 0.002 | 0.906 | 0.082 | Sphingosine 1-phosphate receptor 3 antagonist | 0.082 0.016 DBMET00505 | DBMET00505 | |
| 0.001 | 0.905 | 0.051 | G protein-coupled receptor agonist | 0.051 0.017 DBMET00505 | DBMET00505 | |
| 0.001 | 0.906 | 0.08 | Sphingosine 1-phosphate receptor agonist | 0.08 0.009 DBMET00505 | DBMET00505 | |
| 0.001 | 0.906 | 0.045 | Histamine H2 receptor agonist | 0.045 0.027 DBMET00505 | DBMET00505 | |
| 0.003 | 0.909 | 0.136 | Glutamate (mGluR group III) agonist | 0.136 0.005 DBMET00505 | DBMET00505 | |
| 0.002 | 0.908 | 0.184 | Sphingosine 1-phosphate receptor 4 agonist | 0.184 0.005 DBMET00505 | DBMET00505 | |
| 0.001 | 0.908 | 0.041 | Alpha 1d adrenoreceptor agonist | 0.041 0.025 DBMET00505 | DBMET00505 | |
| 0.003 | 0.91 | 0.107 | Urease inhibitor | 0.107 0.059 DBMET00505 | DBMET00505 | |
| 0.009 | 0.917 | 0.159 | Glutamate (mGluR7) agonist | 0.159 0.009 DBMET00505 | DBMET00505 | |
| 0.001 | 0.909 | 0.035 | Inosine monophosphate dehydrogenase inhibitor | 0.035 0.027 DBMET00505 | DBMET00505 | |
| 0.008 | 0.917 | 0.17 | 3C-like protease (Human coronavirus) inhibitor | 0.17 0.074 DBMET00505 | DBMET00505 | |
| 0.001 | 0.913 | 0.065 | NMDA 2 receptor antagonist | 0.065 0.056 DBMET00505 | DBMET00505 | |
| 0 | 0.913 | 0.019 | Egl nine homolog 3 inhibitor | 0.019 0.004 DBMET00505 | DBMET00505 | |
| 0.003 | 0.916 | 0.244 | Mannose-6-phosphate isomerase inhibitor | 0.244 0.013 DBMET00505 | DBMET00505 | |
| 0.006 | 0.921 | 0.047 | Aggrecanase 1 inhibitor | 0.047 0.017 DBMET00505 | DBMET00505 | |
| 0.001 | 0.917 | 0.042 | Glutamate (mGluR group I) agonist | 0.042 0.04 DBMET00505 | DBMET00505 | |
| 0.001 | 0.917 | 0.079 | Glutamate (mGluR4) agonist | 0.079 0.005 DBMET00505 | DBMET00505 | |
| 0.003 | 0.919 | 0.041 | Carbonic anhydrase I stimulant | 0.041 0.023 DBMET00505 | DBMET00505 | |
| 0.001 | 0.916 | 0.073 | Glucagon receptor antagonist | 0.073 0.005 DBMET00505 | DBMET00505 | |
| 0.002 | 0.919 | 0.044 | Beta adrenoreceptor agonist | 0.044 0.036 DBMET00505 | DBMET00505 | |
| 0.001 | 0.919 | 0.061 | Matrix metalloproteinase (membrane-type) inhibitor | 0.061 0.031 DBMET00505 | DBMET00505 | |
| 0.003 | 0.922 | 0.035 | AMPA receptor agonist | 0.035 0.026 DBMET00505 | DBMET00505 | |
| 0.009 | 0.928 | 0.084 | Glucagon-like peptide 1 receptor antagonist | 0.084 0.005 DBMET00505 | DBMET00505 | |
| 0.001 | 0.921 | 0.05 | RNA-directed RNA polymerase inhibitor | 0.05 0.013 DBMET00505 | DBMET00505 | |
| 0 | 0.92 | 0.019 | Angiotensin AT1B receptor antagonist | 0.019 0.006 DBMET00505 | DBMET00505 | |
| 0.002 | 0.923 | 0.195 | Sphingosine 1-phosphate receptor 2 antagonist | 0.195 0.009 DBMET00505 | DBMET00505 | |
| 0.016 | 0.936 | 0.093 | CC chemokine 5 receptor agonist | 0.093 0.031 DBMET00505 | DBMET00505 | |
| 0.004 | 0.926 | 0.152 | Carbonic anhydrase XV inhibitor | 0.152 0.03 DBMET00505 | DBMET00505 | |
| 0.004 | 0.925 | 0.064 | Endothelin-converting enzyme inhibitor | 0.064 0.023 DBMET00505 | DBMET00505 | |
| 0.004 | 0.926 | 0.252 | Neurotensin receptor agonist | 0.252 0.021 DBMET00505 | DBMET00505 | |
| 0.001 | 0.924 | 0.043 | Integrin alpha2beta1 antagonist | 0.043 0.005 DBMET00505 | DBMET00505 | |
| 0.019 | 0.942 | 0.295 | Catenin beta inhibitor | 0.295 0.005 DBMET00505 | DBMET00505 | |
| 0.002 | 0.925 | 0.152 | Carbonic anhydrase stimulant | 0.152 0.011 DBMET00505 | DBMET00505 | |
| 0.022 | 0.945 | 0.129 | Factor V inhibitor | 0.129 0.031 DBMET00505 | DBMET00505 | |
| 0.002 | 0.925 | 0.043 | MAP3K5 inhibitor | 0.043 0.021 DBMET00505 | DBMET00505 | |
| 0.001 | 0.925 | 0.06 | AMPA 3 receptor antagonist | 0.06 0.006 DBMET00505 | DBMET00505 | |
| 0.001 | 0.925 | 0.046 | Peptide deformylase inhibitor | 0.046 0.011 DBMET00505 | DBMET00505 | |
| 0.002 | 0.927 | 0.194 | Integrin alpha4 antagonist | 0.194 0.004 DBMET00505 | DBMET00505 | |
| 0 | 0.925 | 0.032 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.032 0.007 DBMET00505 | DBMET00505 | |
| 0.003 | 0.929 | 0.047 | Aminopeptidase N inhibitor | 0.047 0.034 DBMET00505 | DBMET00505 | |
| 0.002 | 0.927 | 0.061 | Beta 1 adrenoreceptor antagonist | 0.061 0.035 DBMET00505 | DBMET00505 | |
| 0.002 | 0.928 | 0.016 | Cholecystokinin agonist | 0.016 0.015 DBMET00505 | DBMET00505 | |
| 0.009 | 0.936 | 0.088 | ErbB-3 antagonist | 0.088 0.052 DBMET00505 | DBMET00505 | |
| 0.003 | 0.93 | 0.539 | Integrin antagonist | 0.539 0.004 DBMET00505 | DBMET00505 | |
| 0.002 | 0.93 | 0.071 | Integrin alpha4beta7 antagonist | 0.071 0.004 DBMET00505 | DBMET00505 | |
| 0.002 | 0.931 | 0.076 | Secretase beta inhibitor | 0.076 0.041 DBMET00505 | DBMET00505 | |
| 0.008 | 0.937 | 0.121 | Transcription factor STAT6 inhibitor | 0.121 0.058 DBMET00505 | DBMET00505 | |
| 0.001 | 0.93 | 0.061 | Nerve growth factor antagonist | 0.061 0.009 DBMET00505 | DBMET00505 | |
| 0.001 | 0.931 | 0.031 | Dipeptidyl peptidase II inhibitor | 0.031 0.025 DBMET00505 | DBMET00505 | |
| 0.004 | 0.934 | 0.066 | Aminopeptidase microsomal inhibitor | 0.066 0.035 DBMET00505 | DBMET00505 | |
| 0.002 | 0.933 | 0.026 | Complement factor 1s inhibitor | 0.026 0.014 DBMET00505 | DBMET00505 | |
| 0.002 | 0.932 | 0.076 | Integrin alpha2 antagonist | 0.076 0.005 DBMET00505 | DBMET00505 | |
| 0.002 | 0.933 | 0.055 | Beta 2 adrenoreceptor antagonist | 0.055 0.03 DBMET00505 | DBMET00505 | |
| 0.002 | 0.933 | 0.1 | Glutamate receptor agonist | 0.1 0.037 DBMET00505 | DBMET00505 | |
| 0.009 | 0.941 | 0.064 | Carbonic anhydrase II stimulant | 0.064 0.019 DBMET00505 | DBMET00505 | |
| 0.001 | 0.934 | 0.048 | Benzodiazepine antagonist | 0.048 0.032 DBMET00505 | DBMET00505 | |
| 0 | 0.934 | 0.018 | Integrin alphaVbeta5 antagonist | 0.018 0.005 DBMET00505 | DBMET00505 | |
| 0.001 | 0.935 | 0.039 | HCV NS5B polymerase inhibitor | 0.039 0.015 DBMET00505 | DBMET00505 | |
| 0.001 | 0.937 | 0.09 | Thymidylate synthase inhibitor | 0.09 0.005 DBMET00505 | DBMET00505 | |
| 0.022 | 0.959 | 0.204 | 5 Hydroxytryptamine 3E antagonist | 0.204 0.055 DBMET00505 | DBMET00505 | |
| 0.003 | 0.94 | 0.122 | Histamine N-methyltransferase inhibitor | 0.122 0.028 DBMET00505 | DBMET00505 | |
| 0.001 | 0.938 | 0.061 | Angiotensin AT1 receptor antagonist | 0.061 0.005 DBMET00505 | DBMET00505 | |
| 0 | 0.938 | 0.022 | Egl nine homolog 1 inhibitor | 0.022 0.005 DBMET00505 | DBMET00505 | |
| 0.001 | 0.938 | 0.037 | Calcium-sensing receptor agonist | 0.037 0.009 DBMET00505 | DBMET00505 | |
| 0.002 | 0.94 | 0.087 | Myeloperoxidase inhibitor | 0.087 0.053 DBMET00505 | DBMET00505 | |
| 0.003 | 0.942 | 0.186 | 5 Hydroxytryptamine 1E antagonist | 0.186 0.147 DBMET00505 | DBMET00505 | |
| 0.002 | 0.941 | 0.097 | Metalloproteinase-2 inhibitor | 0.097 0.04 DBMET00505 | DBMET00505 | |
| 0.005 | 0.944 | 0.151 | DNA repair enzyme inhibitor | 0.151 0.03 DBMET00505 | DBMET00505 | |
| 0.002 | 0.941 | 0.11 | Leukotriene A4 hydrolase inhibitor | 0.11 0.005 DBMET00505 | DBMET00505 | |
| 0.001 | 0.942 | 0.055 | Angiotensin II receptor antagonist | 0.055 0.005 DBMET00505 | DBMET00505 | |
| 0.004 | 0.947 | 0.065 | Immunoglobulin Fc receptor antagonist | 0.065 0.017 DBMET00505 | DBMET00505 | |
| 0.006 | 0.95 | 0.164 | Histone acetyltransferase inhibitor | 0.164 0.121 DBMET00505 | DBMET00505 | |
| 0.002 | 0.947 | 0.088 | Sphingosine 1-phosphate receptor 1 antagonist | 0.088 0.012 DBMET00505 | DBMET00505 | |
| 0 | 0.946 | 0.054 | AMPA 1 receptor antagonist | 0.054 0.01 DBMET00505 | DBMET00505 | |
| 0.002 | 0.948 | 0.069 | Beta 3 adrenoreceptor antagonist | 0.069 0.035 DBMET00505 | DBMET00505 | |
| 0.001 | 0.947 | 0.054 | Dihydrofolate reductase inhibitor | 0.054 0.014 DBMET00505 | DBMET00505 | |
| 0 | 0.947 | 0.068 | Fructose-1,6-bisphosphatase inhibitor | 0.068 0.013 DBMET00505 | DBMET00505 | |
| 0.002 | 0.948 | 0.074 | Potassium channel (Tandem pore domain) blocker | 0.074 0.05 DBMET00505 | DBMET00505 | |
| 0.002 | 0.948 | 0.158 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.158 0.133 DBMET00505 | DBMET00505 | |
| 0.002 | 0.95 | 0.178 | Interleukin 1 beta converting enzyme inhibitor | 0.178 0.009 DBMET00505 | DBMET00505 | |
| 0.002 | 0.951 | 0.141 | Falcipain 3 inhibitor | 0.141 0.041 DBMET00505 | DBMET00505 | |
| 0.005 | 0.954 | 0.381 | Insulysin inhibitor | 0.381 0.025 DBMET00505 | DBMET00505 | |
| 0.002 | 0.951 | 0.227 | Pyruvate kinase inhibitor | 0.227 0.068 DBMET00505 | DBMET00505 | |
| 0.001 | 0.951 | 0.043 | Histamine H1 receptor agonist | 0.043 0.032 DBMET00505 | DBMET00505 | |
| 0.002 | 0.953 | 0.112 | Alkaline phosphatase inhibitor | 0.112 0.097 DBMET00505 | DBMET00505 | |
| 0.002 | 0.953 | 0.126 | 5 Hydroxytryptamine 3A agonist | 0.126 0.051 DBMET00505 | DBMET00505 | |
| 0.001 | 0.954 | 0.071 | Potassium channel intermediate-conductance Ca-activated blocker | 0.071 0.025 DBMET00505 | DBMET00505 | |
| 0.002 | 0.955 | 0.076 | Adrenaline agonist | 0.076 0.064 DBMET00505 | DBMET00505 | |
| 0.002 | 0.956 | 0.099 | Sphingosine 1-phosphate receptor antagonist | 0.099 0.022 DBMET00505 | DBMET00505 | |
| 0 | 0.955 | 0.024 | CXC chemokine 2 receptor antagonist | 0.024 0.021 DBMET00505 | DBMET00505 | |
| 0.005 | 0.961 | 0.127 | MAP kinase 3 inhibitor | 0.127 0.115 DBMET00505 | DBMET00505 | |
| 0 | 0.957 | 0.015 | Integrin alpha4beta1 antagonist | 0.015 0.012 DBMET00505 | DBMET00505 | |
| 0.001 | 0.958 | 0.034 | Protein kinase (CK2) beta inhibitor | 0.034 0.022 DBMET00505 | DBMET00505 | |
| 0 | 0.959 | 0.047 | Carnitine palmitoyltransferase 1 inhibitor | 0.047 0.009 DBMET00505 | DBMET00505 | |
| 0 | 0.961 | 0.049 | Carnitine palmitoyltransferase inhibitor | 0.049 0.009 DBMET00505 | DBMET00505 | |
| 0.001 | 0.961 | 0.1 | Protein kinase (CK2) alpha inhibitor | 0.1 0.076 DBMET00505 | DBMET00505 | |
| 0.002 | 0.963 | 0.16 | Anticonvulsant | 0.16 0.117 DBMET00505 | DBMET00505 | |
| 0.002 | 0.963 | 0.07 | Protein kinase C beta inhibitor | 0.07 0.048 DBMET00505 | DBMET00505 | |
| 0.001 | 0.963 | 0.082 | Neutrophil collagenase inhibitor | 0.082 0.031 DBMET00505 | DBMET00505 | |
| 0 | 0.962 | 0.036 | DNA gyrase subunit B inhibitor | 0.036 0.03 DBMET00505 | DBMET00505 | |
| 0.003 | 0.965 | 0.175 | Thiol protease inhibitor | 0.175 0.051 DBMET00505 | DBMET00505 | |
| 0.004 | 0.968 | 0.067 | Corticotropin releasing factor 2 receptor antagonist | 0.067 0.033 DBMET00505 | DBMET00505 | |
| 0.001 | 0.965 | 0.082 | Protein kinase (CK2) inhibitor | 0.082 0.081 DBMET00505 | DBMET00505 | |
| 0.004 | 0.971 | 0.226 | Neuropeptide Y2 antagonist | 0.226 0.082 DBMET00505 | DBMET00505 | |
| 0.001 | 0.968 | 0.07 | Collagenase 3 inhibitor | 0.07 0.032 DBMET00505 | DBMET00505 | |
| 0.001 | 0.968 | 0.103 | Protein kinase C gamma inhibitor | 0.103 0.072 DBMET00505 | DBMET00505 | |
| 0.007 | 0.976 | 0.146 | Nav1.4 sodium channel blocker | 0.146 0.035 DBMET00505 | DBMET00505 | |
| 0 | 0.972 | 0.06 | AMPA receptor antagonist | 0.06 0.025 DBMET00505 | DBMET00505 | |
| 0.002 | 0.974 | 0.125 | Nav1.6 sodium channel blocker | 0.125 0.089 DBMET00505 | DBMET00505 | |
| 0.001 | 0.976 | 0.062 | Epithelial sodium channel blocker | 0.062 0.026 DBMET00505 | DBMET00505 | |
| 0.001 | 0.977 | 0.127 | Neuropeptide Y1 antagonist | 0.127 0.107 DBMET00505 | DBMET00505 | |
| 0.001 | 0.978 | 0.116 | Caspase 7 inhibitor | 0.116 0.017 DBMET00505 | DBMET00505 | |
| 0.004 | 0.987 | 0.046 | CXC chemokine 1 receptor antagonist | 0.046 0.045 DBMET00505 | DBMET00505 | |
| 0.001 | 0.984 | 0.211 | Calpain inhibitor | 0.211 0.104 DBMET00505 | DBMET00505 | |
| 0.001 | 0.985 | 0.212 | Calpain 2 inhibitor | 0.212 0.178 DBMET00505 | DBMET00505 | |
| 0.003 | 0.988 | 0.14 | M17 leucyl aminopeptidase inhibitor | 0.14 0.062 DBMET00505 | DBMET00505 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |